TABLE 1 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies | Synapse
February 22, 2024
TABLE 1 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies
Key Points
Key points are not available for this paper at this time.
Abstract
Pharmacokinetics of BMS-986351 in cynomolgus monkeys (n = 3) after dosing on day 1 and day 15 (values shown are means of repeated measurements)